These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34039737)

  • 41. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
    Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
    J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
    Nagel S; Pommerenke C; Scherr M; Meyer C; Kaufmann M; Battmer K; MacLeod RA; Drexler HG
    PLoS One; 2017; 12(2):e0171164. PubMed ID: 28151996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
    Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
    Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
    Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
    Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric T-cell acute lymphoblastic leukemia.
    Karrman K; Johansson B
    Genes Chromosomes Cancer; 2017 Feb; 56(2):89-116. PubMed ID: 27636224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Ambesi-Impiombato A; De Keersmaecker K; Hadler M; Paietta E; Tallman MS; Rowe JM; Forne C; Rue M; Ferrando AA
    Blood; 2013 Jul; 122(1):74-82. PubMed ID: 23687089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
    Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Bond J; Touzart A; Leprêtre S; Graux C; Bargetzi M; Lhermitte L; Hypolite G; Leguay T; Hicheri Y; Guillerm G; Bilger K; Lhéritier V; Hunault M; Huguet F; Chalandon Y; Ifrah N; Macintyre E; Dombret H; Asnafi V; Boissel N
    Haematologica; 2019 Aug; 104(8):1617-1625. PubMed ID: 30655366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia.
    Busche S; Ge B; Vidal R; Spinella JF; Saillour V; Richer C; Healy J; Chen SH; Droit A; Sinnett D; Pastinen T
    Cancer Res; 2013 Jul; 73(14):4323-36. PubMed ID: 23722552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.
    Villarese P; Lours C; Trinquand A; Le Noir S; Belhocine M; Lhermitte L; Cieslak A; Tesio M; Petit A; LeLorch M; Spicuglia S; Ifrah N; Dombret H; Langerak AW; Boissel N; Macintyre E; Asnafi V
    Leukemia; 2018 Jan; 32(1):61-71. PubMed ID: 28592888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
    Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
    Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
    Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
    Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
    Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
    J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.